Andreas Kluge

Andreas Kluge

Director Ejecutivo en
Therapeia GmbH & Co. Kg
.

Fortuna: 237 M $ al 30/06/2026

Health Technology
Consumer Services
Process Industries

Perfil

Andreas Kluge founded Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002, and Telix Pharmaceuticals Ltd. in 2015, where he worked as Non-Executive Director from 2020 to 2024.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/02/2026 20.675.000 ( 6,09 % ) 237 M $ 30/06/2026

Cargos activos de Andreas Kluge

EmpresasCargoInicio
Director Ejecutivo 01/01/2007
ABX-CRO advanced pharmaceutical services
Fundador 01/08/2002

Antiguos cargos conocidos de Andreas Kluge.

EmpresasCargoFin
TELIX PHARMACEUTICALS LIMITED Fundador 17/10/2024
Director Ejecutivo 01/07/2002
Ver el detalle de la experiencia de Andreas Kluge.

Formación de Andreas Kluge.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

4

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas5

Consumer Services

Process Industries

Health Technology

Health Technology

ABX-CRO advanced pharmaceutical services